CCB Equity
VC Fund
CCB Equity is a professional subsidiary of China Construction Bank engaged in private equity investment business dedicated to the management of national strategic emerging industry development funds (hereinafter referred to as "Zhanxin Fund") and other private equity funds.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 27%
Last updated:
For AI agents: llms.txt
Industries CCB Equity invests in
Stages CCB Equity invests in
Countries CCB Equity invests in
Investment Focus
Industry
- Manufacturing 5 (45%)
- Health Care 3 (27%)
- Medical 2 (18%)
- Software 2 (18%)
- Advanced Materials 2 (18%)
Stage
- Series B 4 (36%)
- Series A 2 (18%)
- Series C 2 (18%)
- Venture - Series Unknown 2 (18%)
- Debt Financing 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Aixin Semiconductor Technology
|
Aixin Semiconductor Technology specializes in the research and development, manufacturing, and sales of semiconductor front-end measurement and testing equipment. It has a production plant of more than 1,000 square meters in Shenzhen, including a thousand-level assembly and commissioning clean room, and a hundred-level, and ten-level laboratoryclean room. | Series B / Jul 20, 2026 | |
Boardstone Intelligence
|
Boardstone Intelligence is a provider of precision 3D inspection solutions and laboratory analysis solutions. | Series B / Mar 04, 2026 | |
|
Hualu New Materials
|
Hualu New Materials is a subsidiary of China National Chemical Engineering Group Corporation, focusing on the research, development, and industrial application of advanced new materials, and leveraging the group’s strong engineering capabilities and resources to support innovation in chemical engineering, manufacturing, and infrastructure projects. | Series A / Jan 06, 2026 | |
AECC Commercial Aircraft Engine
|
AECC offers design, development, production, assembly, testing, and technical consulting of commercial aircraft power services. | Series A / Jun 06, 2025 | |
Sonosemi Medical
|
Sonosemi Medical is a provider of medical devices that specializes in the development of pan-vascular active interventional products, diagnosis, and treatment solutions. | $27.3M / Series B / Oct 26, 2023 | |
Care Medical
|
Care Medical is a membrane science platform that focuses on blood purification and biopharmaceuticals. | $13.6M / Series C / Sep 08, 2023 | |
Fullcryo
|
Fullcryo provides solutions for helium extraction from natural gas, hydrogen liquefaction, and liquefied hydrogen storage. | $111.7M / Series C / Aug 03, 2023 | |
Jiemeng Intelligence
|
Jiemeng Intelligence is a provider, developer, and manufacturing of lithium-ion battery coating equipment. The company focuses on front-end equipment development, design, and manufacture, as well as lithium-ion battery machinery, to provide clients with safe, efficient, and smart new energy equipment solutions. | Venture - Series Unknown / Aug 01, 2023 | |
OptoMedic
|
OptoMedic is specializing in the research and development and production of high-end optical medical devices and systems. | Debt Financing / Jul 12, 2023 | |
Shanghai Desano Pharmaceuticals Investment
|
Desino was founded in 1996 and is headquartered in Shanghai Zhangjiang Hi-Tech Park. The company's anti-AIDS drugs and anti-malarial drugs are the core development areas for the global public health crisis, and are committed to the development, production, registration and global sales of high-quality drugs.The Dyson Company R&D Center islocated in Shanghai and is the National Enterprise Technology Center, the National Anti-AIDS Drug Engineering Technology Research Center and the National Postdoctoral Research Station. | Venture - Series Unknown / Feb 02, 2023 | |
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does CCB Equity invest in?
CCB Equity invests primarily in Manufacturing, Health Care and Medical startups, most often at Series B and Series A stage. Most of the 11 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did CCB Equity last invest?
The most recent investment recorded for CCB Equity closed in Jul 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
